RNS Number : 2070D Renalytix PLC 15 February 2024   Renalytix plc ("Renalytix" or the "Company")   Half Year Report   LONDON and SALT LAKE CITY , February 15, 2024   - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing

RNS Number : 6963C Renalytix PLC 09 February 2024     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Participate in the BTIG MedTech, Digital Health , Life Science & Diagnostic Tools Conference   LONDON and SALT LAKE CITY , February 9, 2024 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX)

RNS Number : 5654C Renalytix PLC 09 February 2024     Renalytix plc ("Renalytix" or the "Company")   Centers for Medicare & Medicaid Services Publishes Draft Local Coverage Determination for KidneyIntelX and kidneyintelX.dkd   LONDON and SALT LAKE CITY , February 9, 2024 - Renalytix plc (NASDAQ:

RNS Number : 9171Z Renalytix PLC 17 January 2024     Renalytix plc ("Renalytix" or the "Company")   Update on kidneyIntelX.dkd Local Coverage Determination Consideration   Local Coverage Determination would result in   contracted coverage for an estimated additional five million Medicare patients  

RNS Number : 1665Z Renalytix PLC 10 January 2024     Renalytix plc ("Renalytix" or the "Company")   New published data for   KidneyIntelX™   New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease   Electronic health record deployment of

RNS Number : 0685X Renalytix PLC 18 December 2023   Renalytix plc ("Renalytix" or the "Company")   Issue of Shares   LONDON and SALT LAKE CITY -   December 18, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX) , announces the repayment of $1.06 million of the Company's convertible bond and the

RNS Number : 0572X Renalytix PLC 15 December 2023   Renalytix plc (" Renalytix " or the " Company ")     Result of AGM   LONDON and SALT LAKE , 15 December 2023   - Renalytix (NASDAQ: RNLX)  (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical

RNS Number : 2472W Renalytix PLC 08 December 2023   Renalytix plc ("Renalytix" or the "Company")   Directorate Change   LONDON and SALT LAKE CITY -   December 8, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX),   an artificial intelligence-enabled in vitro diagnostics company, focused on

RNS Number : 3917U Renalytix PLC 23 November 2023   Renalytix plc ("Renalytix" or the "Company")   Grant of Share Options   LONDON and SALT LAKE CITY -   November 23, 2023 -   Renalytix plc   (NASDAQ: RNLX) (LSE: RENX),   an artificial intelligence-enabled in vitro diagnostics company, focused on

RNS Number : 8806T Renalytix PLC 17 November 2023     Renalytix plc ("Renalytix" or the "Company")   Publication of Annual Report 2023 and Notice of 2023 Annual General Meeting   LONDON and SALT LAKE CITY, UT November, 17 2023 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the Annual